Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$187.64 - $206.25 $10.4 Million - $11.4 Million
55,500 New
55,500 $10.7 Million
Q3 2022

Nov 14, 2022

SELL
$135.27 - $180.11 $3.84 Million - $5.11 Million
-28,389 Reduced 85.8%
4,700 $643,000
Q2 2022

Aug 15, 2022

BUY
$108.81 - $179.33 $2.03 Million - $3.35 Million
18,679 Added 129.63%
33,089 $5.86 Million
Q1 2022

May 13, 2022

SELL
$119.61 - $157.85 $549,009 - $724,531
-4,590 Reduced 24.16%
14,410 $2.08 Million
Q4 2021

Feb 11, 2022

BUY
$142.57 - $190.86 $2.71 Million - $3.63 Million
18,999 Added 1899900.0%
19,000 $2.94 Million
Q3 2021

Nov 12, 2021

SELL
$142.45 - $169.82 $261,253 - $311,449
-1,834 Reduced 99.95%
1 $0
Q2 2021

Aug 16, 2021

SELL
$135.08 - $161.1 $2.82 Million - $3.36 Million
-20,865 Reduced 91.92%
1,835 $290,000
Q1 2021

May 17, 2021

BUY
$137.51 - $190.8 $3.12 Million - $4.33 Million
22,700 New
22,700 $3.15 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.